ALICIA NGUYEN: Open Payments
NPI 1184818114 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,205 in 62 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $884 · 2025 $1,205
Food & beverage: $1,128Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $334 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $203 |
| Janssen Biotech, Inc. | 4 | $128 |
| Lilly USA, LLC | 5 | $124 |
| PFIZER INC. | 4 | $66 |
| Celltrion USA Inc. | 3 | $56 |
| Ipsen Biopharmaceuticals, Inc | 4 | $55 |
| GENZYME CORPORATION | 2 | $45 |
| Aimmune Therapeutics, Inc. | 2 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
Products named: ENTYVIO, SKYRIZI, RINVOQ, TREMFYA, OMVOH, DUPIXENT, VEGZELMA, IQIRVO.
Industry payments across KS — which companies pay providers there.
